Physician

Ronald Paul Hobbs, M.D.

According to 2025 Medicare claims, Ronald Hobbs, M.D. (NPI: 1194986786) practices ophthalmology in the Phoenix-Mesa-Chandler, AZ market, with the plurality of this provider's patient population coming from Maricopa, AZ. This provider's primary affiliated billing organization is ARIZONA RETINA ASSOCIATES, PLLC (NPI: 1891241964; TIN: 812499035) and primary practice location at 85206-6101.

Hobbs' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,471 traditional Medicare patients, billed 82,503 HCPCS/CPT codes, and received $4,023,048 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 569 prescription claims across 170 beneficiaries totaling $19,950 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 7 records totaling $308. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $975,618 to $4,023,048. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $28,694 and ending at $19,950. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.1M$4.1M2015 Medicare payment: $975,618 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,212,249 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $629,587 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,120,809 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,852,929 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,361,102 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,743,410 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,483,046 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,119,837 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,023,048 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20159357,269$975,618
20161,0919,243$1,212,249
20179085,883$629,587
20181,0329,290$1,120,809
20191,27613,322$1,852,929
20201,29513,501$2,361,102
20211,34114,275$2,743,410
20221,47719,926$3,483,046
20231,45055,879$4,119,837
20241,47182,503$4,023,048

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$17K$34K2015 Drug cost: $28,694 (USD; Tot_Drug_Cst)2016 Drug cost: $30,990 (USD; Tot_Drug_Cst)2017 Drug cost: $14,031 (USD; Tot_Drug_Cst)2018 Drug cost: $22,737 (USD; Tot_Drug_Cst)2019 Drug cost: $30,659 (USD; Tot_Drug_Cst)2020 Drug cost: $32,320 (USD; Tot_Drug_Cst)2021 Drug cost: $33,713 (USD; Tot_Drug_Cst)2022 Drug cost: $32,039 (USD; Tot_Drug_Cst)2023 Drug cost: $26,181 (USD; Tot_Drug_Cst)2024 Drug cost: $19,950 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015195555$28,694
2016203557$30,990
2017100276$14,031
2018114378$22,737
2019131474$30,659
2020146541$32,320
2021175604$33,713
2022182647$32,039
2023173644$26,181
2024170569$19,950

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system298298$98
67028Injection of drug into eye6292,673$88
92014Established patient complete exam of visual system1,1981,822$84
J7999Compounded drug, not otherwise classified2451,119$71
92134Imaging of retina1,4564,093$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1044,217$3,295
Brimonidine TartrateBrimonidine Tartrate563,663$2,288
LatanoprostLatanoprost17312,926$1,942
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat816,116$1,474
OfloxacinOfloxacin40638$416

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$308Alimera Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ronald Paul Hobbs, M.D.?

Tedicare shows public-source Medicare data for Ronald Paul Hobbs, M.D. (NPI 1194986786), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ronald Paul Hobbs, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ronald Paul Hobbs, M.D.?

Ronald Paul Hobbs, M.D. is linked to ARIZONA RETINA ASSOCIATES, PLLC (billing NPI 1891241964) in the available physician profile data.

Does Ronald Paul Hobbs, M.D. have Open Payments data?

Ronald Paul Hobbs, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.